Mirati Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirati Therapeutics, Inc. has filed 798 SEC EDGAR filings since 10 May 2013

SEC filing history

Showing 601-625 of 798 matching filings.

Per page
25
Current page
25
4

PRIMARY DOCUMENT

Filing date
19 May 2016
Reporting date
18 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35921

CT ORDER filing

Filing date
16 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2016
Reporting date
05 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35921

DEF 14A

Filing date
19 Apr 2016
Reporting date
18 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87670

SC 13D/A

Filing date
01 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Apr 2016
Reporting date
30 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2016
Reporting date
29 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2016
Reporting date
24 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Mar 2016
Reporting date
21 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
23 Mar 2016
Reporting date
21 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2016
Reporting date
18 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2016
Reporting date
17 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2016
Reporting date
17 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2016
Reporting date
16 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87670

SC 13D/A

Filing date
17 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
09 Mar 2016
Reporting date
09 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87670

VENBIO SELECT ADVISOR LLC

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SCHEDULE 13G AMENDMENT FILING

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87670

SC 13G/A filing

Filing date
09 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35921

8-K

Filing date
26 Jan 2016
Reporting date
22 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .